enprofylline 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| N-methylated xanthine derivatives | 1015 | 41078-02-8 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 3 | Hosey CM, Chan R, Benet LZ |
| Vd (Volume of distribution) | 0.63 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 4 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.55 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 1.80 hours | Lombardo F, Berellini G, Obach RS |
| S (Water solubility) | 5.68 mg/mL | Bocci G, Oprea TI, Benet LZ |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D058917 | Adenosine A2 Receptor Antagonists |
| MeSH PA | D018927 | Anti-Asthmatic Agents |
| MeSH PA | D001993 | Bronchodilator Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D058914 | Purinergic Antagonists |
| MeSH PA | D058915 | Purinergic P1 Receptor Antagonists |
| MeSH PA | D019141 | Respiratory System Agents |
| CHEBI has role | CHEBI:35475 | non-steroidal anti-inflammatory agent |
| CHEBI has role | CHEBI:35523 | bronchodilator |
| CHEBI has role | CHEBI:38070 | antiarrhythmic agent |
| CHEBI has role | CHEBI:49167 | anti-asthmatic drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 7.61 | acidic |
| pKa2 | 8.27 | acidic |
| pKa3 | 2.65 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Adenosine receptor A1 | GPCR | Ki | 4.38 | CHEMBL | |||||
| Adenosine receptor A2b | GPCR | Ki | 5.33 | CHEMBL | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.03 | CHEMBL | |||||
| Adenosine receptor A2a | GPCR | Ki | 4.49 | CHEMBL | |||||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Enzyme | WOMBAT-PK | |||||||
| Adenosine receptor A1 | GPCR | Ki | 4.49 | CHEMBL | |||||
| Adenosine receptor A2a | GPCR | Ki | 4.49 | CHEMBL | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.19 | CHEMBL | |||||
| Adenosine receptor A1 | GPCR | Ki | 4.22 | CHEMBL | |||||
| Adenosine A2a receptor | GPCR | Ki | 4.04 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| D04006 | KEGG_DRUG |
| C0059372 | UMLSCUI |
| CHEBI:126237 | CHEBI |
| CHEMBL279898 | ChEMBL_ID |
| DB00824 | DRUGBANK_ID |
| 1676 | PUBCHEM_CID |
| 4878 | INN_ID |
| C034347 | MESH_SUPPLEMENTAL_RECORD_UI |
| DT7DT5E518 | UNII |
Pharmaceutical products:
None